Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Pittsburgh, PA
SEC filing record 1 source field available
Fiscal year end
31 December
NeuBase Therapeutics, Inc. has filed 670 SEC EDGAR filings since 16 May 2002

SEC filing history

Showing 576-582 of 582 matching filings.

Per page
25
Current page
24
10-Q File 333-88480

QUARTERLY REPORT

Filing date
13 Aug 2010
Reporting date
30 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 333-88480

PERIOD ENDED MARCH 31, 2010

Filing date
17 May 2010
Reporting date
31 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-88480

CURRENT REPORT

Filing date
12 Apr 2010
Reporting date
12 Apr 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 333-88480

FORM-10Q

Filing date
16 Feb 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 333-88480

ANNUAL REPORT

Filing date
19 Jan 2010
Reporting date
30 Sep 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 333-88480

ANNUAL REPORT

Filing date
14 Jan 2010
Reporting date
30 Sep 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 333-88480

ANNUAL REPORT

Filing date
08 Jan 2010
Reporting date
30 Sep 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .